trending Market Intelligence /marketintelligence/en/news-insights/trending/xUMlFergNAmTJEt1EOphrg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Roche again delays $4.3B Spark Therapeutics takeover amid regulatory scrutiny

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Roche again delays $4.3B Spark Therapeutics takeover amid regulatory scrutiny

Roche Holding AG again extended its $4.3 billion takeover offer for Spark Therapeutics Inc. to give additional time to U.S. and U.K. regulators to examine the deal.

In March, Roche launched a buyout offer to acquire all outstanding shares of the Philadelphia-based gene-therapy maker for $114.50 apiece. Roche has already extended the offer period several times from the initial April 3 deadline.

The Swiss drugmaker said the offer will now expire at 5 p.m. ET on Dec. 16, unless further extended.